• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Molecular mechanisms of regulation of glucose-stimulated insulin secretion by novel small-molecule activators and inhibitors in pancreatic beta-cells

Research Project

Project/Area Number 18K06950
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Review Section Basic Section 49010:Pathological biochemistry-related
Research InstitutionGunma University

Principal Investigator

MATSUNAGA Kohichi  群馬大学, 生体調節研究所, 助教 (20570162)

Project Period (FY) 2018-04-01 – 2021-03-31
Project Status Completed (Fiscal Year 2020)
Budget Amount *help
¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2020: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2019: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2018: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Keywordsインスリン分泌 / ケミカルバイオロジー / 化合物ライブラリ / インスリン / β細胞
Outline of Final Research Achievements

To identify novel small-molecules of insulin secretion regulator, we examined high-throughput screening analysis to identify chemical compounds that activate (or inhibit) insulin secretion in pancreatic beta-cells and identified several kinds of compounds as activator (or inhibitor) of insulin secretion. Pull-down assay experiment using chemical compound conjugated magnetic beads revealed that one of the activators binds to mitochondrial protein, VDAC. siRNA-mediated depletion of VDAC1 in INS1 832/13 cells reduced increase of insulin secretion by the activator, and in addition, intracellular ATP level is increased by the activator in beta-cells. These results demonstrate that glucose-stimulated insulin secretion is up-regulated by increase of intracellular ATP level through binding of the novel activator to VDAC protein.

Academic Significance and Societal Importance of the Research Achievements

糖尿病は我が国を含め世界中で増加の一途をたどっており、より副作用の少ない、インスリン分泌をコントロールできる新規薬剤の開発は以前重要な課題の一つです。本研究で行われた網羅的な薬剤スクリーニングにより、新規に発見されたインスリン分泌促進・阻害化合物と、それら同定された化合物の詳細な分子メカニズム解析の知見は、新しい糖尿病薬開発を行うための基盤になると考えています。

Report

(3 results)
  • 2020 Final Research Report ( PDF )
  • 2019 Research-status Report
  • 2018 Research-status Report

URL: 

Published: 2018-04-23   Modified: 2022-01-27  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi